Raj K Vuppalanchi (Raj Vuppalanchi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 53

Top Venues

Alimentary pharmacology & therapeutics

The American journal of gastroenterology

Digestive diseases and sciences

Hepatology (Baltimore, Md.)

Indiana University School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Indiana University School of Medicine

United States

Associate Professor of Medicine :: Medicine- Gastroenterology Hepatology

Publications

Vijay S Are, Mark A Gromski, Fatih Akisik, Eduardo Vilar-Gomez, Craig Lammert, Marwan Ghabril, Raj K Vuppalanchi, Naga Chalasani
Primary Sclerosing Cholangitis Limited to Intrahepatic Bile Ducts Has Distinctly Better Prognosis. Digestive diseases and sciences 69 (4) (2024)
Swetha Parvataneni, Yara Sarkis, Michelle Haugh, Brittany Baker, Qing Tang, Nephew D Lauren, Marwan S Ghabril, Naga P Chalasani, Raj K Vuppalanchi, Eric S Orman, Nicholas Eric Harrison, Archita P Desai
A comprehensive evaluation of emergency department utilization by patients with cirrhosis. The American journal of gastroenterology (2024)
Robert J Fontana, Yi Ju Li, Raj K Vuppalanchi, David E Kleiner, Jiezhun Gu, Hersh Shroff, Lisa B Van Wagner, Paul B Watkins, null null
ERAP-1 and ERAP-2 Variants in Liver Injury After COVID-19 mRNA Vaccination: A US Multicenter Study. The American journal of gastroenterology (2024)
Stephen Caldwell, Ginger Clark, Jeff Teckman, Veeral H Ajmera, Cynthia Behling, Mark Brantly, David Brenner, Jeanine D'Armiento, Michael W Fried, Janani S Iyer, Mattias Mandorfer, Don C Rockey, Monica A Tincopa, Raj K Vuppalanchi, Zobair M Younossi, Aleksander Krag, Alice M Turner, Pavel Strnad
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease. Alimentary pharmacology & therapeutics 59 (10) (2024)
Stephen Caldwell, Ginger Clark, Jeff Teckman, Veeral H Ajmera, Cynthia Behling, Mark Brantly, David Brenner, Jeanine D'Armiento, Michael W Fried, Janani S Iyer, Mattias Mandorfer, Don C Rockey, Monica A Tincopa, Raj K Vuppalanchi, Zobair M Younossi, Aleksander Krag, Alice M Turner, Pavel Strnad
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease. Alimentary pharmacology & therapeutics 59 (10) (2024)
Elizabeth E Williams, Andrea Mladenovic, Dheeksha Ranginani, Regina Weber, Niharika Samala, Samer Gawrieh, Eduardo Vilar-Gomez, Naga Chalasani, Raj K Vuppalanchi
Role of Spleen Stiffness Measurement in the Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease. Digestive diseases and sciences 69 (4) (2024)
Robert J Fontana, Yi Ju Li, Raj K Vuppalanchi, David E Kleiner, Jiezhun Gu, Hersh Shroff, Lisa B Van Wagner, Paul B Watkins, null null
ERAP-1 and ERAP-2 Variants in Liver Injury After COVID-19 mRNA Vaccination: A US Multicenter Study. The American journal of gastroenterology 119 (8) (2024)
Caroline Conlon, Yi-Ju Li, Jawad Ahmad, Huiman Barnhart, Robert J Fontana, Marwan S Ghabril, Paul H Hayashi, David E Kleiner, William M Lee, Victor Navarro, Joseph A Odin, Elizabeth J Phillips, Andrew Stolz, Raj K Vuppalanchi, Dina Halegoua-DeMarzio, null null
Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary pharmacology & therapeutics (2024)
Caroline Conlon, Yi-Ju Li, Jawad Ahmad, Huiman Barnhart, Robert J Fontana, Marwan S Ghabril, Paul H Hayashi, David E Kleiner, William M Lee, Victor Navarro, Joseph A Odin, Elizabeth J Phillips, Andrew Stolz, Raj K Vuppalanchi, Dina Halegoua-DeMarzio, null null
Clinical characteristics and HLA associations of azithromycin-induced liver injury. Alimentary pharmacology & therapeutics 60 (6) (2024)
Raj K Vuppalanchi, Stephen Caldwell, Arun J Sanyal, Amir Nikooie, Yuanyuan Tang, Deborah A Robins, Bram Brouwers, Mark L Hartman
Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failures. Alimentary pharmacology & therapeutics (2024)
Raj K Vuppalanchi, Stephen Caldwell, Arun J Sanyal, Amir Nikooie, Yuanyuan Tang, Deborah A Robins, Bram Brouwers, Mark L Hartman
Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failures. Alimentary pharmacology & therapeutics 60 (1) (2024)
Robert J Fontana, Yi Ju Li, Raj K Vuppalanchi, David E Kleiner, Jiezhun Gu, Hersh Shroff, Lisa B Van Wagner, Paul B Watkins, null null
ERAP-1 and ERAP-2 Variants in Liver Injury After COVID-19 mRNA Vaccination: A US Multicenter Study. The American journal of gastroenterology 119 (8) (2024)
Elizabeth E Williams, Andrea Mladenovic, Dheeksha Ranginani, Regina Weber, Niharika Samala, Samer Gawrieh, Eduardo Vilar-Gomez, Naga Chalasani, Raj K Vuppalanchi
Role of Spleen Stiffness Measurement in the Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease. Digestive diseases and sciences 69 (4) (2024)
Swetha Parvataneni, Yara Sarkis, Michelle Haugh, Brittany Baker, Qing Tang, Lauren D Nephew, Marwan S Ghabril, Naga P Chalasani, Raj K Vuppalanchi, Eric S Orman, Nicholas Eric Harrison, Archita P Desai
A Comprehensive Evaluation of Emergency Department Utilization by Patients With Cirrhosis. The American journal of gastroenterology (2024)
Elizabeth E Williams, Andrea Mladenovic, Dheeksha Ranginani, Regina Weber, Niharika Samala, Samer Gawrieh, Eduardo Vilar-Gomez, Naga Chalasani, Raj K Vuppalanchi
Role of Spleen Stiffness Measurement in the Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease. Digestive diseases and sciences (2024)
Robert J Fontana, Yi Ju Li, Raj K Vuppalanchi, David E Kleiner, Jiezhun Gu, Hersh Shroff, Lisa B Van Wagner, Paul B Watkins, null null
ERAP-1 and ERAP-2 Variants in Liver Injury After COVID-19 mRNA Vaccination: A US Multicenter Study. The American journal of gastroenterology 119 (8) (2024)
Stephen Caldwell, Ginger Clark, Jeff Teckman, Veeral H Ajmera, Cynthia Behling, Mark Brantly, David Brenner, Jeanine D'Armiento, Michael W Fried, Janani S Iyer, Mattias Mandorfer, Don C Rockey, Monica A Tincopa, Raj K Vuppalanchi, Zobair M Younossi, Aleksander Krag, Alice M Turner, Pavel Strnad
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease. Alimentary pharmacology & therapeutics 59 (10) (2024)
Raj K Vuppalanchi, Stephen Caldwell, Arun J Sanyal, Amir Nikooie, Yuanyuan Tang, Deborah A Robins, Bram Brouwers, Mark L Hartman
Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failures. Alimentary pharmacology & therapeutics 60 (1) (2024)
Vijay S Are, Mark A Gromski, Fatih Akisik, Eduardo Vilar-Gomez, Craig Lammert, Marwan Ghabril, Raj K Vuppalanchi, Naga Chalasani
Primary Sclerosing Cholangitis Limited to Intrahepatic Bile Ducts Has Distinctly Better Prognosis. Digestive diseases and sciences 69 (4) (2024)
Naim Alkhouri, Deanna McCarthy, Anne-Cécile V Bayne, Traci Blonquist, Karin Yurko-Mauro, Raj K Vuppalanchi, Eric Lawitz, Naga P Chalasani
The effect of vitamin E and docosahexaenoic acid ethyl ester on Metabolic Dysfunction-Associated steatotic Liver Disease (MASLD)-A randomised, double-blind, placebo-controlled, parallel-group clinical trial (PUVENAFLD). Alimentary pharmacology & therapeutics 60 (5) (2024)
Vijay S Are, Mark A Gromski, Fatih Akisik, Eduardo Vilar-Gomez, Craig Lammert, Marwan Ghabril, Raj K Vuppalanchi, Naga Chalasani
Primary Sclerosing Cholangitis Limited to Intrahepatic Bile Ducts Has Distinctly Better Prognosis. Digestive diseases and sciences (2024)
Stephen Caldwell, Ginger Clark, Jeff Teckman, Veeral H Ajmera, Cynthia Behling, Mark Brantly, David Brenner, Jeanine D'Armiento, Michael W Fried, Janani S Iyer, Mattias Mandorfer, Don C Rockey, Monica A Tincopa, Raj K Vuppalanchi, Zobair M Younossi, Aleksander Krag, Alice M Turner, Pavel Strnad
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease. Alimentary pharmacology & therapeutics (2024)
Robert J Fontana, Yi Ju Li, Raj K Vuppalanchi, David E Kleiner, Jiezhun Gu, Hersh Shroff, Lisa B Van Wagner, Paul B Watkins, null null
ERAP-1 and ERAP-2 Variants in Liver Injury After COVID-19 mRNA Vaccination: A US Multicenter Study. The American journal of gastroenterology (2024)
Elizabeth E Williams, Andrea Mladenovic, Dheeksha Ranginani, Regina Weber, Niharika Samala, Samer Gawrieh, Eduardo Vilar-Gomez, Naga Chalasani, Raj K Vuppalanchi
Role of Spleen Stiffness Measurement in the Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease. Digestive diseases and sciences 69 (4) (2024)
Robert J Fontana, Yi Ju Li, Raj K Vuppalanchi, David E Kleiner, Jiezhun Gu, Hersh Shroff, Lisa B Van Wagner, Paul B Watkins, null null
ERAP-1 and ERAP-2 Variants in Liver Injury After COVID-19 mRNA Vaccination: A US Multicenter Study. The American journal of gastroenterology 119 (8) (2024)
Vijay S Are, Mark A Gromski, Fatih Akisik, Eduardo Vilar-Gomez, Craig Lammert, Marwan Ghabril, Raj K Vuppalanchi, Naga Chalasani
Primary Sclerosing Cholangitis Limited to Intrahepatic Bile Ducts Has Distinctly Better Prognosis. Digestive diseases and sciences 69 (4) (2024)
Raj K Vuppalanchi, Stephen Caldwell, Arun J Sanyal, Amir Nikooie, Yuanyuan Tang, Deborah A Robins, Bram Brouwers, Mark L Hartman
Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failures. Alimentary pharmacology & therapeutics 60 (1) (2024)
Naim Alkhouri, Deanna McCarthy, Anne-Cécile V Bayne, Traci Blonquist, Karin Yurko-Mauro, Raj K Vuppalanchi, Eric Lawitz, Naga P Chalasani
The effect of vitamin E and docosahexaenoic acid ethyl ester on Metabolic Dysfunction-Associated steatotic Liver Disease (MASLD)-A randomised, double-blind, placebo-controlled, parallel-group clinical trial (PUVENAFLD). Alimentary pharmacology & therapeutics (2024)
Eric S Orman, Archita P Desai, Marwan S Ghabril, Lauren D Nephew, Kavish R Patidar, John Holden, Niharika R Samala, Samer Gawrieh, Raj K Vuppalanchi, Margaret Sozio, Marco Lacerda, Eduardo Vilar-Gomez, Craig S Lammert, Suthat Liangpunsakul, David Crabb, Howard Masuoka, Lara Dakhoul, Minmin Pan, Sujuan Gao, Naga Chalasani
Thirty-day readmissions are largely not preventable in patients with cirrhosis. The American journal of gastroenterology (2023)
Mazen Noureddin, Edward Mena, Raj K Vuppalanchi, Niharika R Samala, Micaela Wong, Fabiana Pacheco, Prido Polanco, Celine Sakkal, Ani Antaramian, Devon Chang, Nabil Noureddin, Anita Kohli, Stephen A Harrison, Samer Gwarieh, Rohit L Loomba, Emily Truong
Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores. Hepatology communications 7 (5) (2023)
Mazen Noureddin, Edward Mena, Raj K Vuppalanchi, Niharika R Samala, Micaela Wong, Fabiana Pacheco, Prido Polanco, Celine Sakkal, Ani Antaramian, Devon Chang, Nabil Noureddin, Anita Kohli, Stephen A Harrison, Samer Gwarieh, Rohit L Loomba, Emily Truong
Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores. Hepatology communications 7 (5) (2023)
Arun J Sanyal, Sudha S Shankar, Katherine P Yates, James Bolognese, Erika Daly, Clayton A Dehn, Brent A Neuschwander-Tetri, Kris Kowdley, Raj K Vuppalanchi, Cynthia Behling, James Tonascia, Anthony E Samir, Claude B Sirlin, Sarah P Sherlock, Kathryn Fowler, Helen Heymann, Tania N Kamphaus, Stephen Caldwell, Roberto A Calle
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis. Nature medicine (2023)
Mazen Noureddin, Edward Mena, Raj K Vuppalanchi, Niharika R Samala, Micaela Wong, Fabiana Pacheco, Prido Polanco, Celine Sakkal, Ani Antaramian, Devon Chang, Nabil Noureddin, Anita Kohli, Stephen A Harrison, Samer Gwarieh, Rohit L Loomba, Emily Truong
Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores. Hepatology communications 7 (5) (2023)
Raj K Vuppalanchi, Kris V Kowdley
Editorial: The evolving paradigms and treatments for primary biliary cholangitis. Alimentary pharmacology & therapeutics 59 (2) (2023)
Raj K Vuppalanchi, Kris V Kowdley
Editorial: The evolving paradigms and treatments for primary biliary cholangitis. Alimentary pharmacology & therapeutics 59 (2) (2023)
Eduardo Vilar-Gomez, Raj K Vuppalanchi, Samer Gawrieh, Niharika R Samala, Naga P Chalasani
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology (Baltimore, Md.) (2023)
Mazen Noureddin, Edward Mena, Raj K Vuppalanchi, Niharika R Samala, Micaela Wong, Fabiana Pacheco, Prido Polanco, Celine Sakkal, Ani Antaramian, Devon Chang, Nabil Noureddin, Anita Kohli, Stephen A Harrison, Samer Gwarieh, Rohit L Loomba, Emily Truong
Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores. Hepatology communications 7 (5) (2023)
Eduardo Vilar-Gomez, Raj K Vuppalanchi, Samer Gawrieh, Niharika R Samala, Naga P Chalasani
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology (Baltimore, Md.) 77 (4) (2023)
Eduardo Vilar-Gomez, Raj K Vuppalanchi, Samer Gawrieh, Niharika R Samala, Naga P Chalasani
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology (Baltimore, Md.) 77 (4) (2023)
Eduardo Vilar-Gomez, Raj K Vuppalanchi, Samer Gawrieh, Niharika R Samala, Naga P Chalasani
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology (Baltimore, Md.) 77 (4) (2023)
Melissa Palmer, David E Kleiner, Zachary Goodman, Elizabeth Brunt, Mark I Avigan, Arie Regev, Paul H Hayashi, James H Lewis, Ruby Mehta, Stephen A Harrison, Massimo Siciliano, Charles A McWherter, Raj K Vuppalanchi, Cynthia Behling, Veronica Miller, Naga P Chalasani, Arun J Sanyal
Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver Forum. Alimentary pharmacology & therapeutics (2023)
Alexander Culver, Matthew Hamang, Yan Wang, Huaizhou Jiang, Jennifer Yanum, Emily White, Samer Gawrieh, Raj K Vuppalanchi, Naga P Chalasani, Guoli Dai, Benjamin C Yaden
GDF8 Contributes to Liver Fibrogenesis and Concomitant Skeletal Muscle Wasting. Biomedicines 11 (7) (2023)
Andrea Mladenovic, Raj K Vuppalanchi, Archita P Desai
A Primer to the Diagnostic and Clinical Utility of Spleen Stiffness Measurement in Patients With Chronic Liver Disease. Clinical liver disease 19 (3) (2022)
Shireesha Vuppalanchi, Raj K Vuppalanchi
Editorial: liver and kidney injury from remdesivir-an issue not as much as its purpose. Alimentary pharmacology & therapeutics 55 (11) (2022)
Tinsay A Woreta, Mark L Van Natta, Mariana Lazo, Arunkumar Krishnan, Brent A Neuschwander-Tetri, Rohit Loomba, Anna Mae Diehl, Manal F Abdelmalek, Naga Chalasani, Samer Gawrieh, Srinivasan Dasarathy, Raj K Vuppalanchi, Mohammad S Siddiqui, Kris V Kowdley, Arthur McCullough, Norah A Terrault, Cynthia Behling, David E Kleiner, Mark Fishbein, Paula Hertel, Laura A Wilson, Emily P Mitchell, Laura A Miriel, Jeanne M Clark, James Tonascia, Arun J Sanyal, null null
Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms. PloS one 17 (4) (2022)
Raj K Vuppalanchi, Marwan S Ghabril
Review article: clinical assessment of suspected drug-induced liver injury and its management. Alimentary pharmacology & therapeutics 56 (11-12) (2022)
Marwan S Ghabril, Jiayi Ma, Kavish R Patidar, Lauren D Nephew, Archita P Desai, Eric S Orman, Raj K Vuppalanchi, Chandrashekhar A Kubal, Naga P Chalasani
Eight-Fold Increase in Dietary Supplement-Related Liver Failure Leading to Transplant Waitlisting Over the Last Quarter Century in the United States. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2021)
Raj K Vuppalanchi, Rohit Loomba
Noninvasive Tests to Phenotype Nonalcoholic Fatty Liver Disease: Sequence and Consequences of Arranging the Tools in the Tool Box. Hepatology (Baltimore, Md.) 73 (6) (2021)
Eduardo Vilar-Gomez, Lauren D Nephew, Raj K Vuppalanchi, Samer Gawrieh, Andrea Mladenovic, Francis Pike, Niharika Samala, Naga P Chalasani
High quality diet, physical activity and college education are associated with low risk of NAFLD among the U.S. population. Hepatology (Baltimore, Md.) (2021)
Jay H Hoofnagle, Herbert L Bonkovsky, Elizabeth J Phillips, Yi-Ju Li, Jawad Ahmad, Huiman Barnhart, Francisco Durazo, Robert J Fontana, Jiezhun Gu, Ikhlas Khan, David E Kleiner, Christopher Koh, Don C Rockey, Leonard B Seeff, Jose Serrano, Andrew Stolz, Hans L Tillmann, Raj K Vuppalanchi, Victor J Navarro, null null
HLA-B*35:01 and Green Tea-Induced Liver Injury. Hepatology (Baltimore, Md.) 73 (6) (2021)
John E Eaton, Raj K Vuppalanchi, Rajender Reddy, Sanjaya Kumar Satapathy, Bilal Ali, Patrick S Kamath
Liver Injury in Patients With Cholestatic Liver Disease Treated With Obeticholic Acid. Hepatology (Baltimore, Md.) 71 (4) (2020)
Michael B Zemel, Orville Kolterman, Mary Rinella, Raj K Vuppalanchi, Omar Flores, A Sidney Barritt, Mohammad Bilal Siddiqui, Naga P Chalasani
Randomized Controlled Trial of a Leucine-Metformin-Sildenafil Combination (NS-0200) on Weight and Metabolic Parameters. Obesity (Silver Spring, Md.) 27 (1) (2020)
Raj K Vuppalanchi, Lindsay Yoder
When Enough Is Not Enough: Screening, Brief Intervention and Referral to Treatment for Hepatitis C in Patients Presenting to the Emergency Department. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 25 (11) (2019)

Raj K Vuppalanchi (Raj Vuppalanchi)

Publication Activity (10 Years)

Top Topics

Top Venues